N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

被引：0
|
作者：
Oliver Wirths
Susanne Walter
Inga Kraus
Hans W. Klafki
Martina Stazi
Timo J. Oberstein
Jorge Ghiso
Jens Wiltfang
Thomas A. Bayer
Sascha Weggen
机构：
[1] University Medical Center (UMG),Division of Molecular Psychiatry
[2] Georg-August-University,Department of Psychiatry and Psychotherapy
[3] University Medical Center (UMG),Department of Neuropathology
[4] Georg-August-University,Department of Psychiatry and Psychotherapy
[5] Heinrich-Heine-University,Department of Pathology
[6] Friedrich-Alexander-University of Erlangen-Nuremberg,Departments of Psychiatry
[7] New York University School of Medicine,Institute for Research in Biomedicine (iBiMED), Medical Sciences Department
[8] New York University School of Medicine,undefined
[9] German Center for Neurodegenerative Diseases (DZNE),undefined
[10] University of Aveiro,undefined
来源：
Alzheimer's Research & Therapy | / 9卷
关键词：
Alzheimer’s disease; N-truncated Amyloid-β; Immunohistochemistry; Mouse model; Postmortem; 5XFAD; APP/PS1KI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models
    Wisniewski, Thomas
    Boutajangout, Allal
    BRAIN STRUCTURE & FUNCTION, 2010, 214 (2-3): : 201 - 218
  • [32] Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
    Thomas Wisniewski
    Allal Boutajangout
    Brain Structure and Function, 2010, 214 : 201 - 218
  • [33] Transgenic mouse models of Alzheimer's disease: phenotype and application
    Higgins, GA
    Jacobsen, H
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (5-6): : 419 - 438
  • [34] Transgenic models for Alzheimer's disease
    Duff, K
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1998, 24 (02) : 101 - 103
  • [35] N-Truncated Aβ Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer's Disease
    Bayer, Thomas A.
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [36] Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease
    Marcello, Andrea
    Wirths, Oliver
    Schneider-Axmann, Thomas
    Degerman-Gunnarsson, Malin
    Lannfelt, Lars
    Bayer, Thomas A.
    NEUROBIOLOGY OF AGING, 2011, 32 (08) : 1379 - 1387
  • [37] Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models
    Reinert, Jochim
    Richard, Bernhard C.
    Klafki, Hans W.
    Friedrich, Beate
    Bayer, Thomas A.
    Wiltfang, Jens
    Kovacs, Gabor G.
    Ingelsson, Martin
    Lannfelt, Lars
    Paetau, Anders
    Bergquist, Jonas
    Wirths, Oliver
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 24
  • [38] Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models
    Jochim Reinert
    Bernhard C. Richard
    Hans W. Klafki
    Beate Friedrich
    Thomas A. Bayer
    Jens Wiltfang
    Gabor G. Kovacs
    Martin Ingelsson
    Lars Lannfelt
    Anders Paetau
    Jonas Bergquist
    Oliver Wirths
    Acta Neuropathologica Communications, 4
  • [39] N-terminal truncated amyloid β-peptides and Alzheimer's disease -: Reply
    Russo, C
    Schettini, G
    Saido, TC
    Gambetti, P
    Tabaton, M
    Teller, JT
    NEUROBIOLOGY OF AGING, 2001, 22 (03) : 345 - 345
  • [40] Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis
    Duff, K
    NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE, 2001, 67 : 195 - 202
12345